MAPT and tauopathy: Based upon these in vitro observations, we developed a built-in adjuvanted FlaB-TauRD fusion polypeptide as an antitauopathy vaccine and confirmed that active immunization with the FlaB-TauRD vaccine ameliorated tauopathy in a P301S human tau transgenic mouse model.